Related Experiment Videos
Prolonged hemodynamic effect of a slow-release nitroglycerin ointment
The American Journal of Cardiology
|September 1, 1986
Summary
A new slow-release nitroglycerin (NTG) ointment offers sustained hemodynamic improvements for over 24 hours. This novel formulation may provide a convenient once-daily treatment option for angina and heart failure.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Nitroglycerin (NTG) ointment is established for treating angina pectoris and congestive heart failure.
- Conventional NTG ointments typically provide relief for 4 to 6 hours.
Purpose of the Study:
- To evaluate the hemodynamic effects of a novel slow-release NTG ointment.
- To determine the duration of action for the slow-release NTG formulation.
Main Methods:
- Twenty patients with coronary artery disease participated in the study.
- Serial gated equilibrium radionuclide ventriculography was used to assess hemodynamic parameters.
- Measurements were taken before, during continuous once-daily use (≥24 hours), and after cessation of the slow-release NTG ointment.
Main Results:
- Slow-release NTG significantly reduced left ventricular volumes at rest and during exercise (p < 0.005).
- Ejection fraction increased significantly at rest (p < 0.0005), and peak systolic pressure to end-systolic volume ratio improved (p < 0.05).
- Hemodynamic improvements persisted for at least 24 hours and returned to baseline 4 days after treatment cessation.
Conclusions:
- Slow-release NTG ointment demonstrates prolonged hemodynamic benefits lasting over 24 hours.
- This formulation may offer a practical once-daily therapeutic option for managing angina pectoris and congestive heart failure.
- The effects are reversible upon discontinuation of the treatment.